Breaking Cataract Cornea Hyperopia LASIK Myopia Patient Education PRK Surgery Next-generation IOLs advance complex cataract care Ağustos 26, 2025
Breaking Cataract Patient Education Surgery Technology Alcon presenting at APACRS 2025 Ağustos 21, 2025
Breaking Cornea Innovation Patient Education Treatment Surgical innovation in dry eye disease: Salivary gland transplant Ağustos 27, 2025
Breaking Cataract Patient Education Recommendation Surgery Treatment Global Spotlight: The Most Cost-Effective Countries for Cataract Surgery Eylül 10, 2025
Home Patient Education The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye – Nature Share your love
The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: Report 17, a risk factor model for posterior capsule rupture | Eye Nature Source: Author: | Date: 2024-09-19 07:00:00 Source: Author: | Date: 2024-09-19 07:00:00 Share your love Previous Yazı A comparative evaluation of deep learning approaches for ophthalmology | Scientific Reports - Nature Next Yazı Embracing generative AI in ophthalmology - British Journal of Ophthalmology Related Posts FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology TimesEkim 3, 2025 AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology TimesEkim 3, 2025 Q&A: The ARCHER trial and the importance of continued GA research | Ophthalmology TimesEkim 3, 2025 Leave a ReplyCancel ReplyE-posta adresiniz yayınlanmayacak. Gerekli alanlar * ile işaretlenmişlerdir Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Yorum gönder
FDA grants breakthrough therapy designation to Nacuity’s NPI-001 for retinitis pigmentosa | Ophthalmology TimesEkim 3, 2025
AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA | Ophthalmology TimesEkim 3, 2025
